Sally Hed Dahlquist speaks to Edge Magazine

Join host Elise Marquam Jahns and CEO Sally Hed Dahlquist of Immunochemistry Technologies as they share groundbreaking, scientific and technological approaches that enable the timely assessment of chemotherapy effectiveness, and other biomedical research and...